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Abstract
Accumulating research suggests that the pro-inflammatory cytokine interleukin-1β (IL-1β) has a 
modulatory effect on the hippocampus, a brain structure important for learning and memory as 
well as linked with both psychiatric and neurodegenerative disorders. Here, we used an imaging 
genetics strategy to test an association between an IL-1β polygenic score and hippocampal volume 
in two independent samples. Our polygenic score was derived using summary statistics from a 
recent genome-wide association study (GWAS) of circulating cytokines that included IL-1β 
(N=3,309). In the first sample of 512 non-Hispanic Caucasian university students (274 women, 
mean age 19.78 ± 1.24 years) from the Duke Neurogenetics Study, we identified a significant 
positive correlation between IL-1β polygenic scores and hippocampal volume. This positive 
association was successfully replicated in a second sample of 7,960 white British volunteers 
(4,158 women, mean age 62.63±7.45 years) from the UK Biobank. Our results lend further 
support in humans, to the link between IL-1β and the structure of the hippocampus.
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Introduction
The hippocampus, a key brain structure supporting learning and memory, has been 
implicated in the pathophysiology of both psychiatric and neurodegenerative disorders. For 
example, smaller hippocampal volume has been noted in schizophrenia (van Erp et al., 
2016), depression (Schmaal et al., 2016), and bipolar disorder (Hibar et al., 2016), as well as 
in neurodegenerative disorders such as Alzheimer’s disease (Bobinski et al., 1999). More 
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broadly, smaller hippocampal volume has been associated with poorer cognitive function in 
healthy adults (Zhu, Chen, Dang, Dong, & Lin, 2017). Thus, advancing the understanding of 
the factors that contribute to individual differences in hippocampal volume, can shed light on 
both normal and abnormal function.
It is now clear that inflammation has far-reaching modulatory effects on the central nervous 
system (Miller, Haroon, Raison, & Felger, 2013; Yirmiya & Goshen, 2011). Amongst these, 
the pro-inflammatory cytokine interleukin (IL)-1β, which can affect the physiology of most 
cells and is a key mediator of autoinflammatory, autoimmune, infectious, and degenerative 
diseases (Garlanda, Dinarello, & Mantovani, 2013), may be particularly important for 
understanding hippocampal structure. First, receptors for IL-1β are highly expressed in the 
dentate gyrus (Ban, Milon, Prudhomme, Fillion, & Haour, 1991; Loddick, Liu, Takao, 
Hashimoto, & De Souza, 1998), where neural stem cells reside in the adult mammalian brain 
(Gage, 2000). Second, IL-1β has been shown to affect neurogenesis, synaptic strengthening, 
and long term potentiation (LTP) in the hippocampus (Avital et al., 2003; Bellinger, 
Madamba, & Siggins, 1993; Goshen et al., 2008; Green & Nolan, 2012; Katsuki et al., 1990; 
Wu, Montgomery, Rivera-Escalera, Olschowka, & O’Banion, 2013). All of these processes 
can affect volume. For example, in animal models, interrupting IL-1β signaling, by a 
deletion of IL-1 receptor type 1 or by administration of IL-1 receptor antagonist (IL-1Ra), 
blocks the antineurogenic effect of stress on the hippocampus (Koo & Duman, 2008). 
Further, increasing IL-1β signaling, by exogenous administration of this cytokine, mimics 
the effect of stress, and decreases hippocampal cell proliferation (Koo & Duman, 2008). In 
humans, Zunszain et al., (2012) demonstrated that IL-1β directly inhibits neurogenesis in 
hippocampal progenitor cells in vitro.
It is notable that while high levels of IL-1β are usually associated with deleterious effects on 
the hippocampus, this cytokine has also been shown to support normal brain function, by 
affecting neurogenesis, LTP, learning, and memory. Such salubrious effects seem to depend 
on the target organ, expression level/dose, and timing (reviewed in Donzis & Tronson, 2014; 
Spulber, Bartfai, & Schultzberg, 2009). For instance, one study in mice showed that LTP is 
associated with an increase in IL-1β gene expression in hippocampal cells and that IL-1Ra 
led to a reversible inhibition of LTP (Schneider et al., 1998). Another study found that a 30-
minute IL-1β (1 ng/mL) administration impaired N-methyl-D-aspartate (NMDA) receptor 
dependent LTP, but not NMDA receptor independent LTP, in mouse hippocampal slices 
(Hoshino, Hasegawa, Kamiya, & Morimoto, 2017).
Despite the vast literature demonstrating the effects of IL-1β on hippocampal volume and 
studies showing that IL-1β levels are moderately to highly heritable (Brodin et al., 2015; De 
Craen et al., 2005), to our knowledge, the genetic influences of IL-1β on hippocampal 
volume in humans have only been previously shown in one candidate gene study (Raz, 
Daugherty, Bender, Dahle, & Land, 2015). In a sample of 80 individuals, Raz et al. found 
that the T allele of the single nucleotide polymorphism (SNP) rs16944 in the IL-1β gene was 
associated with smaller hippocampal volume. Notably however, candidate gene studies 
suffer from low replicability rates (e.g., Avinun, Nevo, Knodt, Elliott, & Hariri, 2018), and 
more specifically, findings regarding the biological functionality of rs16944 have not been 
consistent across studies (e.g., Chen et al., 2006; Iacoviello et al., 2005).
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Polygenic scores that aggregate information from across the genome to summarize genome-
wide genetic influences on an outcome of interest, have been successfully used in previous 
research to model individual differences (e.g., Domingue, Belsky, Conley, Harris, & 
Boardman, 2015; Domingue, Liu, Okbay, & Belsky, 2017; Stephan, Sutin, Luchetti, Caille, 
& Terracciano, 2018). A recent study conducted separate genome-wide analyses of 
circulating blood levels of 41 cytokines, including IL-1β, in up to 8,293 adult Finns from 
three independent population cohorts (Ahola-Olli et al., 2017). Using meta-analysis of the 
associations from each cohort, and after controlling for sex, age, genetic ancestry, and body 
mass index (BMI), the authors found 27 genome-wide significant SNPs for one or more 
cytokines. Specifically, the sample used for the analysis of IL-1β included 3,309 individuals 
from two studies: the Cardiovascular Risk in Young Finns Study and the FINRISK study. No 
genome-wide significant SNPs were found for IL-1β, possibly due to the stringent 
correction for multiple comparisons using a significance threshold of p<(5*10–8)/41. 
However, genome-wide statistical significance is not a prerequisite for leveraging GWAS 
summary statistics to model individual differences in target phenotypes. In fact, polygenic 
scores based on summary statistics of all available SNPs irrespective of nominal significance 
(i.e., p=1) have been shown to account for most of the variance in the phenotype of interest 
(Dudbridge, 2013; Ware et al., 2017).
Here, we used summary statistics from the above study to generate polygenic scores to 
model potential individual differences in circulating levels of IL-1β. There are two main 
advantages to this approach. First, accurate measures of IL-1β levels are not readily 
available to researchers as the human IL-1β may not directly cross the blood brain barrier, 
requiring highly invasive sampling of cerebrospinal fluid (reviewed in Banks, 2005). 
Second, polygenic scores, reflecting inherent differences between individuals, more readily 
allow for speculation regarding the directionality of effects than direct measures of 
contemporaneous IL-1β levels that can reflect differences that precede or follow changes in 
hippocampal volume.
Based on the available literature, we hypothesized that higher polygenic IL-1β scores, which 
putatively correlate with higher circulating levels of the pro-inflammatory cytokine, would 
be associated with smaller hippocampal volume. We tested our hypothesis in two 
independent samples: 1) 512 non-Hispanic Caucasian university students from the Duke 
Neurogenetics Study; and 2) 7,960 adult white British volunteers from the UK Biobank. In 
the analyses of both samples, in addition to sex, age, and ethnicity, we also included 
socioeconomic status (SES), stress, and BMI, as covariates of no interest because of prior 
links between these measures and brain volume (Gunstad et al., 2008; Hackman, Farah, & 
Meaney, 2010; Lupien, McEwen, Gunnar, & Heim, 2009) as well as inflammation (Pollitt et 
al., 2008; Silverman & Sternberg, 2012; Tam, Clement, Baur, & Tordjman, 2010).
Materials and methods
Participants
Our first sample consisted of 512 self-reported non-Hispanic Caucasian participants (274 
women, mean age 19.78±1.24 years) from the Duke Neurogenetics Study (DNS) who were 
not genetically related and for whom there was complete data on genotypes, structural MRI, 
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and all covariates detailed below. All procedures were approved by the Duke University 
Medical Center Institutional Review Board, and participants provided informed written 
consent before study initiation. All participants were free of the following study exclusions: 
1) medical diagnoses of cancer, stroke, diabetes requiring insulin treatment, chronic kidney 
or liver disease, or lifetime history of psychotic symptoms; 2) use of psychotropic, 
glucocorticoid, or hypolipidemic medication; and 3) conditions affecting cerebral blood flow 
and metabolism (e.g., hypertension).
Current and lifetime DSM-IV (the Diagnostic and Statistical Manual of Mental Disorders) 
Axis I or select Axis II disorders (antisocial personality disorder and borderline personality 
disorder), were assessed with the electronic Mini International Neuropsychiatric Interview 
(Lecrubier et al., 1997) and Structured Clinical Interview for the DSM-IV Axis II subtests 
(First, Gibbon, Spitzer, Williams, & Benjamin, 1997), respectively. Importantly, neither 
current nor lifetime diagnosis were an exclusion criterion, as the DNS seeks to establish 
broad variability in multiple behavioral phenotypes related to psychopathology. Of the 512 
participants with data included in our analyses, 114 individuals had at least one past or 
current DSM-IV diagnosis, including 65 with alcohol use disorders, 19 with non-alcohol 
substance use disorders, 26 with major depressive disorders, 16 with bipolar disorders, 13 
with panic disorder (no agoraphobia), 12 with panic disorder including agoraphobia, 5 with 
social anxiety disorder, 8 with generalized anxiety disorder, 6 with obsessive compulsive 
disorder, and 3 with eating disorders. However, no participants, regardless of diagnosis, were 
taking any psychoactive medication during or at least 14 days prior to their participation.
Our second sample, consisted of 7,960 white British participants (4,158 women, mean age 
62.63±7.45 years), with complete genotype, structural MRI, and covariate data from the UK 
Biobank (www.ukbiobank.ac.uk; Sudlow et al., 2015), which includes over 500,000 
participants, between the ages of 40 and 69 years, who were recruited within the UK 
between 2006 and 2010. Participants in the imaging sample of the UK Biobank were 
excluded if they had any metal inside their body or an implanted medical device that could 
create imaging artefacts or pose a risk during MRI, if they were likely to find it difficult to 
lie still, or if they were unlikely to tolerate the imaging due to reported claustrophobia. The 
UK Biobank study has been approved by the National Health Service Research Ethics 
Service (reference: 11/NW/0382), and our analyses were conducted under UK Biobank 
application 28174.
Socioeconomic status (SES)
Prior research has reported associations between SES and brain volume (Hackman et al., 
2010). In the DNS, we controlled for possible SES effects using the “social ladder” 
instrument (Adler, Epel, Castellazzo, & Ickovics, 2000), which asks participants to rank 
themselves relative to other people in the United States (or their origin country) on a scale 
from 0–10, with people who are best off in terms of money, education, and respected jobs, at 
the top (10) and people who are worst off at the bottom (0).
In the UK Biobank, we used the Townsend deprivation index, which was assessed at 
recruitment, as a means to control for SES. The Townsend deprivation index is a composite 
measure of deprivation based on unemployment, non-car ownership, non-home ownership, 
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and household overcrowding. It was calculated before participants joined the UK Biobank 
and was based on the preceding national census data, with each participant assigned a score 
corresponding to the postcode of their home dwelling. Scoring was reversed so that high 
values represented high SES.
Body mass index (BMI)
Prior research has reported associations between BMI and brain volume (Gunstad et al., 
2008). In both DNS and UK Biobank samples, BMI was calculated based on the height and 
weight of the participants. In the DNS, this calculation was based on imperial system values 
(pounds/inches2*703), while in the UK Biobank the metric system was used (kg/m2). For 
the UK Biobank we used the BMI from the imaging assessment visit.
Recent life stress
Prior research has reported associations between stress and hippocampal volume (Lupien et 
al., 2009). In the DNS, we controlled for the effects of life stress during the year prior to 
assessment using a summation of 38 negatively valenced items (as described in Avinun et 
al., 2017; Nikolova, Bogdan, Brigidi, & Hariri, 2012) from the Life Events Scale for 
Students (LESS; Clements & Turpin, 1996).
In the UK Biobank, life stress during the two years prior to imaging was assessed based on a 
count of 6 stressful events (illness of participant, illness of a close relative, death of a 
partner/spouse, death of a close relative, marital separation/divorce, and financial 
difficulties).
Race/Ethnicity
Because self-reported race and ethnicity are not always an accurate reflection of genetic 
ancestry, an analysis of identity by state of whole-genome SNPs was performed in PLINK 
(Purcell et al., 2007). The first two multidimensional scaling components within the non-
Hispanic Caucasian subgroup were used as covariates in analyses of data from the DNS. The 
decision to use only the first two components was based on an examination of a scree plot of 
the eigenvalue of each component.
For analyses of data from the UK Biobank, only those who were ‘white British’ based on 
both self-identification and a principal components analysis of genetic ancestry were 
included. Additionally, the first 10 multidimensional scaling components received from the 
UK Biobank’s team were included as covariates as previously done (e.g., Whalley et al., 
2016).
Genotyping
In the DNS, DNA was isolated from saliva using Oragene DNA self-collection kits (DNA 
Genotek) customized for 23andMe (www.23andme.com). DNA extraction and genotyping 
were performed through 23andMe by the National Genetics Institute (NGI), a CLIA-
certified clinical laboratory and subsidiary of Laboratory Corporation of America. One of 
two different Illumina arrays with custom content was used to provide genome-wide SNP 
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data, the HumanOmniExpress (N=326) or HumanOmniExpress-24 (N=186; Do et al., 2011; 
Eriksson et al., 2010; Tung et al., 2011).
In the UK Biobank, samples were genotyped using either the UK BiLEVE (N=775) or the 
UK Biobank axiom (N=7,185) array. Details regarding the UK Biobank’s quality control can 
be found elsewhere (Bycroft et al., 2017).
Quality control and polygenic scoring
For genetic data from both the DNS and UK Bionbank, PLINK v1.90 (Purcell et al., 2007) 
was used to perform quality control analyses and exclude SNPs or individuals based on the 
following criteria: missing genotype rate per individual >.10, missing rate per SNP >.10, 
minor allele frequency <.01, and Hardy-Weinberg equilibrium p<1e-6. Additionally, in the 
UK Biobank, quality control variables that were provided with the dataset were used to 
exclude participants based on a sex mismatch (genetic sex different from reported sex), a 
genetic relatedness to another participant, and outliers for heterozygosity or missingness.
Polygenic scores were calculated using PLINK’s (Purcell et al., 2007) “--score” command 
based on published SNP-level summary statistics from a recent GWAS that included IL-1β 
blood levels as an outcome of interest (Ahola-Olli et al., 2017). SNPs from the IL-1β GWAS 
were matched with SNPs from the DNS and UK Biobank datasets. For each SNP the 
number of the alleles (0, 1, or 2) associated with IL-1β blood levels was multiplied by the 
effect estimated in the GWAS. The polygenic score for each individual was an average of 
weighted IL-1β-associated alleles. All SNPs that could be matched with SNPs from the 
DNS or UK Biobank were used regardless of effect size and significance in the original 
GWAS, as previously recommended and shown to be effective (Dudbridge, 2013; Ware et 
al., 2017). A total of 428,481 SNPs in the DNS and 567,256 SNPs in the UK Biobank were 
included in the respective polygenic scores. The approach described here for the calculation 
of the polygenic score was successfully used in previous studies (e.g., Domingue et al., 
2015; Domingue et al., 2017; Stephan et al., 2018).
Structural MRI
In the DNS, data were collected at the Duke-UNC Brain Imaging and Analysis Center using 
one of two identical research-dedicated GE MR750 3T scanners (General Electric 
Healthcare, Little Chalfont, United Kingdom) equipped with high-power high-duty cycle 50-
mT/m gradients at 200 T/m/s slew rate, and an eight-channel head coil for parallel imaging 
at high bandwidth up to 1 MHz. T1-weighted images were obtained using a 3D Ax FSPGR 
BRAVO with the following parameters: TR = 8.148 ms; TE = 3.22 ms; 162 axial slices; flip 
angle, 12°; FOV, 240 mm; matrix =256×256; slice thickness = 1 mm with no gap; and total 
scan time = 4 min and 13 s.
To generate regional measures of brain volume, anatomical images for each subject were 
first skull-stripped using ANTs (Klein et al., 2009), then submitted to Freesurfer’s (Version 
5.3) recon-all with the “-noskullstrip” option (Dale, Fischl, & Sereno, 1999; Fischl, Sereno, 
& Dale, 1999), using an x86_64 linux cluster running Scientific Linux. The gray and white 
matter boundaries determined by recon-all were visually inspected using FreeSurfer QA 
Tools (https://surfer.nmr.mgh.harvard.edu/fswiki/QATools) and determined to be sufficiently 
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accurate for all subjects. Volume measures for the hippocampus from each participant’s 
aseg.stats file were averaged across hemispheres. Estimated Total Intracranial Volume 
(eTIV) was used to quantify intracranial volume (ICV).
In the UK Biobank, imaging data were collected on a Siemens Skyra 3T, with a standard 
Siemens 32-channel RF receive head coil, and preprocessed with FSL packages (the FMRIB 
Software Library; Jenkinson, Beckmann, Behrens, Woolrich, & Smith, 2012). Segmentation 
of T1-weighted structural images into subcortical structures was done using FIRST 
(FMRIB’s Integrated Registration and Segmentation Tool; Patenaude, Smith, Kennedy, & 
Jenkinson, 2011). Additional information on the imaging processing pipeline conducted for 
the UK Biobank can be found elsewhere (Alfaro-Almagro et al., 2018; Miller et al., 2016; 
online documentation: biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). Here as well, left 
and right hippocampal volumes were averaged to create a mean volume variable. ICV was 
estimated based on the sum of white matter, gray matter and ventricular cerebrospinal fluid 
volumes.
Statistical analyses
Mplus version 7 (RRID:SCR_015578; Muthén & Muthén, 2007) was used to conduct linear 
regression analyses. In both samples the covariates of no interest included: participants’ sex 
(coded as 0=males, 1=females), age (in the DNS 18–22 years were coded as 1–5), ethnicity 
components, BMI, SES, recent life stress, and intracranial volume. Maximum likelihood 
estimation with robust standard errors, which is robust to non-normality, was used in the 
regression analyses. Standardized results for these analyses are presented.
Results
Descriptive statistics and correlations between study variables are presented in Table 1 and 
Table 2, respectively. IL-1β polygenic scores were positively and significantly associated 
with SES in both samples, therefore the findings below are reported with and without SES as 
a covariate. The polygenic scores did not differ between men and women (DNS: F[1, 510] 
= .642, p=.42; UK Biobank: [1, 7958] = .021, p=.88).
The analysis in the DNS sample revealed that IL-1β polygenic scores significantly predicted 
hippocampal volume, so that higher scores were associated with larger volume (without 
SES: β=.078, SE=.037, p=.036; with SES: β=.075, SE=.037, p=.044). Of the covariates, 
only ICV was significantly associated with hippocampal volume (β=.626, SE=.044, p<.001). 
The R2 of the model with SES was .425 (SE=.03, p<.001). Comparing the R2 of the model 
with the IL-1β polygenic score to the R2 of a model without it, indicated that the variance 
explained by the polygenic score was small (R2=.005). In the UK Biobank analysis, IL-1β 
polygenic score was also positively and significantly associated with hippocampal volume 
(without SES: β=.023, SE=.010, p=.020; with SES: β=.022, SE=.010, p=.021). Of the 
covariates, other than ICV (β=.425, SE=.014, p<.001), both age (β=−.177, SE=.010, p<.001) 
and stress (β=−.025, SE=.010, p=.010) negatively predicted hippocampal volume. The R2 of 
the model with SES was .248 (SE=.01, p<.001). Comparing the R2 of the model with the 
IL-1β polygenic score to the R2 of a model without it, indicated that the variance explained 
by the polygenic score was small (R2=.001).
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As post-hoc analyses we tested each hemisphere separately with the same covariates, 
including SES. This was done to examine whether one hemisphere was driving the observed 
associations. In the DNS the effect was stronger and only significant in the left hippocampus 
(LEFT: β=.109, SE=.039, p=.005; RIGHT: β=.024, SE=.036, p=.503). In the UK Biobank, 
the effect was also only significant in the left hippocampus (LEFT: β=.022, SE=.010, p=.
025; RIGHT: β=.018, SE=.010, p=.072).
Additionally, in the DNS we were able to test whether a DSM-IV diagnosis, as determined 
by a structured clinical interview, biased the findings. With the addition of a variable 
indicating a DSM-IV diagnosis (0-no diagnosis; 1-at least one DSM-IV diagnosis) as a 
covariate, the positive association of the IL-1β polygenic score with hippocampal volume 
remained significant (β=.074, SE=.037, p=.047).
Discussion
Here we report that a polygenic score for circulating levels of the pro-inflammatory cytokine 
IL-1β, based on summary statistics from a recent GWAS, is associated with hippocampal 
volume in two independent samples: the DNS, which consists of 18–22 year old university 
students, and the UK Biobank, which consists of 45–78 year old volunteers. Contrary to our 
hypothesis, which was based on previous research demonstrating that high IL-1β levels 
suppress neurogenesis (Goshen et al., 2008; Koo & Duman, 2008; Zunszain et al., 2012), we 
found that higher IL-1β polygenic scores, which have been associated with increased levels 
of this pro-inflammatory cytokine, were associated in both samples with larger hippocampal 
volume.
While high levels of IL-1β may adversely affect neurogenesis, they have been shown to 
increase gliogenesis (Chen et al., 2013; Crampton, Collins, Toulouse, Nolan, & O’Keeffe, 
2012). In other words, IL-1β may reduce neurogenesis, not by increasing cell death, but by 
affecting cell fate determination and promoting the differentiation of neural progenitor cells 
into glial cells (Crampton et al., 2012). Furthermore, nonpathological/physiological levels of 
IL-1β have been shown to support neurogenesis in transgenic mice that overexpress human 
soluble IL-1Ra (Spulber, Oprica, Bartfai, Winblad, & Schultzberg, 2008) and in rats treated 
with IL-1Ra (Bachstetter et al., 2011). Additional processes that may explain the observed 
positive association between IL-1β polygenic scores and hippocampal volume, are the 
effects of IL-1β on LTP (Avital et al., 2003) and dendritic spine size (Goshen et al., 2009). 
Mice with impaired IL-1 signaling are characterized by deficits in memory function, reduced 
LTP, and reduced dendritic spine size (Avital et al., 2003; Goshen et al., 2008; Goshen et al., 
2007; Yirmiya, Winocur, & Goshen, 2002), suggesting that certain levels of IL-1β are 
required for normal brain function. It is possible that the higher levels of IL-1β, as modeled 
by the polygenic score, are within an optimal range that leads to an advantageous function of 
this cytokine in promoting synaptic integrity and plasticity. Further studies, combining 
genetic, immune, and structural brain measurements during various stages in development 
are needed to shed light on the processes that may underlie the positive association between 
IL-1β polygenic scores and hippocampal volume.
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Although our study has several strengths, including the use of two independent samples with 
markedly different characteristics (e.g., young university students versus older community 
volunteers) and a GWAS-derived functionally informed polygenic score, it is not without 
limitations. First, similar to other studies that rely on samples of university students and/or 
volunteers, neither the DNS nor the UK Biobank (Fry et al., 2017) represent the general 
population. Similarly, it should be kept in mind that we restricted our analyses to non-
Hispanic Caucasians. As a result, further studies are needed to test the generalizability of our 
findings. Second, we did not examine specific hippocampal subregions, such as the dentatge 
gyrus, which may exhibit preferential sensitivity to variability in IL-1β signaling (Ban et al., 
1991; Loddick et al., 1998). Such subregional analyses require higher resolution structural 
data. Third, the IL-1β GWAS only included 3,309 individuals, which limits the power to 
identify all meaningfully associated SNPs. As has been observed with other phenotypes 
(e.g., educational attainment; Plomin & von Stumm, 2018), vastly larger GWASs will be 
needed to develop more precise polygenic scores for IL-1β. Lastly, as cytokine levels were 
not measured in our samples, we were not able to validate the functionality of the IL-1β 
polygenic score or examine how it correlates with other pro-inflammatory markers. Such 
data are necessary for better understanding the underlying mechanism of our observed 
associations, which cannot establish a causative role of IL-1β levels in hippocampal volume. 
It should be noted that levels of inflammatory cytokines, including IL-1β, increase with age 
(Brüünsgaard & Pedersen, 2003) and that this cytokine has been shown to affect brain 
processes in an age dependent manner (Bachstetter et al., 2011; Griffin et al., 2006; Spulber 
et al., 2008). Consequently, the processes that underlie the links between the IL-1β 
polygenic score and hippocampal volume may differ between the samples and require 
further research. Additionally, as the polygenic score included SNPs that span the entire 
genome, the related processes may not only affect circulating IL-1β levels differently across 
the lifespan, but also include pathways that do not involve direct effects of IL-1β. These 
limitations notwithstanding, our results further support the association between IL-1β and 
hippocampal volume in humans and motivate additional research on the links between an 
IL-1β polygenic score, inflammation, and brain volume.
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